114 related articles for article (PubMed ID: 9325291)
1. Isolation from phage display libraries of single chain variable fragment antibodies that recognize conformational epitopes in the malaria vaccine candidate, apical membrane antigen-1.
Fu Y; Shearing LN; Haynes S; Crewther P; Tilley L; Anders RF; Foley M
J Biol Chem; 1997 Oct; 272(41):25678-84. PubMed ID: 9325291
[TBL] [Abstract][Full Text] [Related]
2. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
Burns JM; Flaherty PR; Nanavati P; Weidanz WP
Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
[TBL] [Abstract][Full Text] [Related]
3. Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.
Lynch MM; Cernetich-Ott A; Weidanz WP; Burns JM
Clin Vaccine Immunol; 2009 Mar; 16(3):293-302. PubMed ID: 19116303
[TBL] [Abstract][Full Text] [Related]
4. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
Amante FH; Crewther PE; Anders RF; Good MF
J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
6. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes.
Crewther PE; Matthew ML; Flegg RH; Anders RF
Infect Immun; 1996 Aug; 64(8):3310-7. PubMed ID: 8757869
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.
Xu H; Hodder AN; Yan H; Crewther PE; Anders RF; Good MF
J Immunol; 2000 Jul; 165(1):389-96. PubMed ID: 10861076
[TBL] [Abstract][Full Text] [Related]
8. Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.
Burns JM; Flaherty PR; Romero MM; Weidanz WP
Vaccine; 2003 May; 21(17-18):1843-52. PubMed ID: 12706668
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
Woehlbier U; Epp C; Hackett F; Blackman MJ; Bujard H
Malar J; 2010 Mar; 9():77. PubMed ID: 20298576
[TBL] [Abstract][Full Text] [Related]
10. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi.
Anders RF; Crewther PE; Edwards S; Margetts M; Matthew ML; Pollock B; Pye D
Vaccine; 1998; 16(2-3):240-7. PubMed ID: 9607037
[TBL] [Abstract][Full Text] [Related]
11. Identification of antigenically active tryptic fragments of apical membrane antigen-1 (AMA1) of Plasmodium chabaudi malaria: strategies for assembly of immunologically active peptides.
Salvatore D; Hodder AN; Zeng W; Brown LE; Anders RF; Jackson DC
Vaccine; 2002 Oct; 20(29-30):3477-84. PubMed ID: 12297393
[TBL] [Abstract][Full Text] [Related]
12. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
13. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.
Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B
PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1.
Thomas AW; Trape JF; Rogier C; Goncalves A; Rosario VE; Narum DL
Am J Trop Med Hyg; 1994 Dec; 51(6):730-40. PubMed ID: 7810805
[TBL] [Abstract][Full Text] [Related]
15. Single-chain antibody fragment specific for Plasmodium vivax Duffy binding protein.
Kim SH; Hwang SY; Lee YS; Choi IH; Park SG; Kho WG
Clin Vaccine Immunol; 2007 Jun; 14(6):726-31. PubMed ID: 17460118
[TBL] [Abstract][Full Text] [Related]
16. Mixed allele malaria vaccines: host protection and within-host selection.
Barclay VC; Chan BH; Anders RF; Read AF
Vaccine; 2008 Nov; 26(48):6099-107. PubMed ID: 18804509
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2.
Leow CH; Jones M; Cheng Q; Mahler S; McCarthy J
Malar J; 2014 Jul; 13():277. PubMed ID: 25037150
[TBL] [Abstract][Full Text] [Related]
18. Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.
Narum DL; Ogun SA; Thomas AW; Holder AA
Infect Immun; 2000 May; 68(5):2899-906. PubMed ID: 10768987
[TBL] [Abstract][Full Text] [Related]
19. Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria.
Lal AA; Hughes MA; Oliveira DA; Nelson C; Bloland PB; Oloo AJ; Hawley WE; Hightower AW; Nahlen BL; Udhayakumar V
Infect Immun; 1996 Mar; 64(3):1054-9. PubMed ID: 8641760
[TBL] [Abstract][Full Text] [Related]
20. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.
Thera MA; Coulibaly D; Kone AK; Guindo AB; Traore K; Sall AH; Diarra I; Daou M; Traore IM; Tolo Y; Sissoko M; Niangaly A; Arama C; Baby M; Kouriba B; Sissoko MS; Sagara I; Toure OB; Dolo A; Diallo DA; Remarque E; Chilengi R; Noor R; Sesay S; Thomas A; Kocken CH; Faber BW; Imoukhuede EB; Leroy O; Doumbo OK
Malar J; 2016 Aug; 15(1):442. PubMed ID: 27577237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
